Rahul Banerjee, MD, FACP ✓

@RahulBanerjeeMD · Seattle, WA · joined 25 Mar 2009

Associate Professor @UWMedicine @fredhutch. Goals: improve patient experience in myeloma: ⬇️ dex, 🙅🏼‍♂️ 24-hr urines, et al. COI: https://t.co/3Uuojuio6R

12 241Followers

4 066Following

35 608Posts total

104.8KViews on collected posts

Последние посты

Rahul Banerjee, MD, FACP ✓@RahulBanerjeeMD8 Sep

Not 🌹 by any other name, but "RT" by any other name... RCT of 🇺🇸 adults (not pts) with cancer vignettes. Clear preference for "radiotherapy" > "radiation therapy." I'm grateful to rad onc colleagues who see many pts with multiple myeloma... I'll start using this term instead! h

949 views · 1 likes · 0 reposts · 0 replies Open on X →

Rahul Banerjee, MD, FACP ✓@RahulBanerjeeMD4 Sep

This year, SUCCESSOR-2 showed half the risk of myeloma progression... using half the dose of a drug we commonly use. Let's dig into the evidence! cc @szusmani @khancology Watch the rest of the series from @mlieducation & get CE credit at https://t.co/rALTPoKlKB #RRMM #mmsm htt

2:25

772 views · 7 likes · 0 reposts · 0 replies Open on X →

Rahul Banerjee, MD, FACP ✓@RahulBanerjeeMD4 Sep

Very rarely can we as a field point to a single clinician-researcher who made a whole field possible. Everything that any trainee has ever learned about MGUS, they learned from work led by Dr. Kyle. Truly inspiring for all of us in the myeloma field. @VincentRK @IMFmyeloma 2.3K views · 34 likes · 1 reposts · 0 replies Open on X →

Rahul Banerjee, MD, FACP ✓@RahulBanerjeeMD4 Sep

Not a clinic goes by where I don’t directly or indirectly reference the incredible work of Robert Kyle. When they speak of standing on the shoulders of giants there was no greater giant than he ! @MayoClinic @IMFmyeloma #mmsm https://t.co/elxkPAQGvz

4.1K views · 37 likes · 7 reposts · 2 replies Open on X →

Rahul Banerjee, MD, FACP ✓@RahulBanerjeeMD4 Sep

This is the type of data we are all excited to see!! As I remember you saying a few months ago, mechanisms of #MMsm resistance appear totally different (and less common) with TCE + CD38 vs traditional TCE monotherapy. Turns out that everyone needs friends... BsAbs included! 2.5K views · 15 likes · 4 reposts · 1 replies Open on X →

Rahul Banerjee, MD, FACP ✓@RahulBanerjeeMD4 Sep

@RahulBanerjeeMD @BloodPortfolio @paurotero @AjaiChari @mvmateos @AnnaSureda5 @DholariaMD @DoctorAKrishnan Been preaching that for a while ….similar data in the works with Talq about to be submitted. TCE + CD38 eliminates Ag escape resistant clones and enhances immune response. W 3.6K views · 14 likes · 2 reposts · 1 replies Open on X →

Rahul Banerjee, MD, FACP ✓@RahulBanerjeeMD5 Aug

Can a single word influence cancer treatment preferences? In our randomized experiment, calling the same treatment “radiotherapy” rather than “radiation therapy” increased preference for radiation treatment by 8.3 percentage points. Just published in @IJROBP: 12.3K views · 35 likes · 16 reposts · 3 replies Open on X →

Rahul Banerjee, MD, FACP ✓@RahulBanerjeeMD4 Jan 2025

@RahulBanerjeeMD @BloodJournal @SWOG @jmikhaelmd @VincentRK @Bethfaiman @MMKingT Love this editorial from @jmikhaelmd and Susan Harding to accompany your work @RahulBanerjeeMD! But, I like my visual better... it shows the impact of [40mgx4daysx3weeksx6months] vs [40mgx1dayx3wee

2.6K views · 8 likes · 2 reposts · 1 replies Open on X →

Rahul Banerjee, MD, FACP ✓@RahulBanerjeeMD27 Sep 2024

@RahulBanerjeeMD @BloodJournal @SWOG @jmikhaelmd @VincentRK @Bethfaiman @MMKingT Congrats Rahul - great work here! 678 views · 6 likes · 2 reposts · 1 replies Open on X →

Rahul Banerjee, MD, FACP ✓@RahulBanerjeeMD27 Sep 2024

@RahulBanerjeeMD @BloodJournal @SWOG @jmikhaelmd @VincentRK @Bethfaiman @MMKingT Congratulations, will have this to read soon I am all to lower doses of Dex 726 views · 6 likes · 1 reposts · 2 replies Open on X →

Rahul Banerjee, MD, FACP ✓@RahulBanerjeeMD26 Sep 2024

Grateful to @BloodJournal, co-authors, and @SWOG for making this #downwithdex piece possible! Dex 40mg weekly in #MMsm induction: 1️⃣ Not practical even for trial-enrolled patients 2️⃣ Does not improve PFS vs ⬇️ dex Twitter 🧵 once I’m back from #IMS24! https://t.co/1Sy1WQpHjk

74.2K views · 220 likes · 48 reposts · 24 replies Open on X →

На фоне аккаунтов своего размера

7 постов за последние 90 дней рядом с диапазоном 10K–100K подписчиков. показывается широко, но откликается мало кто.

Медианные просмотры2 546этот аккаунт1 033медиана для 10K–100K

Охват, %20.80%этот аккаунт3.60%медиана для 10K–100K

Вовлечённость, %0.79%этот аккаунт1.69%медиана для 10K–100K

Показатель	Этот аккаунт	Медиана для 10K–100K	Отношение
Медианные просмотры на пост	2 546	1 033	2.46×
Охват (просмотры ÷ подписчики)	20.80%	3.60%	5.78×
Вовлечённость	0.79%	1.69%	0.46×

Другие в этом диапазоне → Сравнить с другим аккаунтом → Как считаются эти ориентиры →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

74.2K26 Sep

72627 Sep

678

2.6K4 Jan

12.3K5 Aug

3.6K4 Sep

2.5K

4.1K

2.3K

772

9498 Sep

Last 11 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.41%26 Sep

1.24%27 Sep

1.33%

0.50%4 Jan

0.51%5 Aug

0.49%4 Sep

0.79%

1.16%

1.51%

0.91%

0.32%8 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.69%.

What the audience does

Likes65.7%383 in total

Reposts14.2%83 in total

Replies6.0%35 in total

Quotes4.3%25 in total

Bookmarks9.8%57 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Последние посты

На фоне аккаунтов своего размера

Growth & engagement

Views per post

Engagement rate per post

What the audience does

Похожие аккаунты